Search
Close this search box.

Abstract

Daniel Tang talks to Sankeetha Nadarajah, Commissioning Editor (Bioanalysis), regarding the China Bioanalysis Forum (CBF), in which Daniel was one of the co-founders and remains as its co-chair. Daniel is currently the CEO of UP Pharma, a biologics focused bioanalytical CRO in China.

Keywords:

  • CBF
  • China bioanalysis regulation
  • GLP
Scroll to Top